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Abstract
Mammographic density (MD) is a quantitative trait, measurable in all women, and is among the 
strongest markers of breast cancer risk. The population-based epidemiology of MD has revealed 
genetic, lifestyle and societal/environmental determinants, but studies have largely been conducted 
in women with similar westernized lifestyles living in countries with high breast cancer incidence 
rates. To benefit from the heterogeneity in risk factors and their combinations worldwide, we 
created an International Consortium on Mammographic Density (ICMD) to pool individual-level 
epidemiological and MD data from general population studies worldwide. ICMD aims to 
characterize determinants of MD more precisely, and to evaluate whether they are consistent 
across populations worldwide. We included 11755 women, from 27 studies in 22 countries, on 
whom individual-level risk factor data were pooled and original mammographic images were re-
read for ICMD by a core team to obtain standardized comparable MD data. In the present article, 
we present (i) the rationale for this consortium; (ii) characteristics of the studies and women 
included; and (iii) study methodology to obtain comparable MD data from original re-read films. 
We also highlight the risk factor heterogeneity captured by such an effort and, thus, the unique 
insight the pooled study promises to offer through wider exposure ranges, different confounding 
structures and enhanced power for sub-group analyses.
1. Introduction
Since Wolfe's first studies linking mammographic parenchymal patterns to breast cancer 
(BC) risk in 1976, breast density – typically measured on a mammogram as mammographic 
density (MD) – is now recognized as one of the strongest risk factors for this malignancy 
[1-3]. Several features of MD make its population-level research feasible and particularly 
informative. MD is a continuous trait, quantifiable and, in theory, measurable in virtually all 
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women who are eligible to receive a mammogram. High MD is associated with a large 
population attributable fraction for BC in high-risk countries [4]. Several observations 
suggest that MD is on a causal pathway for BC, including that tumours arise within localised 
areas of dense tissue [5], MD and BC have a partially shared genetic basis [6] and the effects 
of several risk BC factors have concordant effects on MD, and some may be mediated 
through MD [7,8]. An understanding of population-level MD distributions and determinants 
may inform the aetiology of this common cancer in women worldwide.
Over the last 3 decades, important determinants of MD have been revealed, including 
genetic factors [9] and lifestyle and societal/environmental influences such as reproductive 
factors, alcohol intake, smoking and measures of growth and body size [7,10-14]. 
Acquisition of this knowledge benefitted greatly from the availability of mammograms in 
organized BC screening programmes, but consequently the populations most studied to date 
have had lifestyles typical of high income countries (e.g. low parity, late age at first birth, 
relative young age at menarche and tall stature). Studying MD in populations with more 
diverse lifestyles, as can be found across countries and ethnic groups, might be more 
informative. This approach has already been taken in an international study of women in the 
US, Norway, Hawaii and Japan [15], and in multi-ethnic studies [16-20]. We extended this 
concept by establishing an International Consortium of MD (ICMD) studies that is enriched 
by the inclusion of ethnic groups and countries which span the lowest to the highest BC 
incidence rates worldwide.
An international study of MD will shed light on the MD range at a given age, whether MD 
reflects an inherent feature of breast biology in all women, and the effect of a broader range 
of lifestyles not observable in a single population – e.g., after many pregnancies and years of 
breast feeding. The objectives of ICMD are thus to establish a resource platform of 
individual-level risk factor and standardized comparable MD data from ethnically and 
internationally diverse populations and use this resource to investigate the determinants of 
MD worldwide, whether they are consistent across countries, women and menopausal status, 
and whether differences in population-level MD distributions reflect differences in 
population-level BC incidence rates.
2. Methods
Study and sample selection
The International Consortium of Mammographic Density (ICMD) is co-ordinated by the 
International Agency for Research on Cancer (IARC). In ICMD, we pooled individual-level 
MD and epidemiologic data from studies of breast cancer-free women worldwide. ICMD 
eligibility criteria were first applied at the study-level and then at the individual-level, as 
follows. Eligible studies were those of women who underwent mammography for the 
purpose of screening, had retrievable mammographic images in electronic format and 
individual-level risk factor information. Studies conducted in mammography settings that 
were exclusively for symptomatic disease or for women with a personal or family history of 
breast cancer were excluded. From within eligible studies, an individual woman was eligible 
for inclusion if she was 35 years or over at the time of mammography, if at least one of her 
mammograms was available and if, at the minimum, she had information for the calculation 
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or estimation of age, parity and body mass index (BMI) at mammography. Women with a 
personal history of breast cancer were excluded.
Studies conducted in populations with diverse BC incidence rates were targeted and invited 
to participate in ICMD. To achieve such diversity, we included studies across all continents 
and multi-ethnic studies, given known geographic and ethnicity-associated variations in BC 
incidence rates [21]. Studies were identified through existing research networks, through 
consultation with collaborators in Asia, Africa and South America, and finally through 
internet-searches of screening programmes in areas of the world that were not already 
represented. In total, 27 studies contributed to ICMD, some of which included multiple 
ethnic groups, thus ICMD includes 40 study- and ethnicity-specific groups, hereafter 
referred to as “population groups”. Each ICMD participating study gained local ethics 
approval and the overall consortium was approved by the IARC ethics committee (IEC 
12-34).
Determinants of MD will initially be investigated separately in pre and post-menopausal 
women in each population group to examine whether associations hold across women 
worldwide and across major reproductive-defined periods in women's lives. To enable these 
investigations, we aimed to include an equal number of women (n=200), randomly selected 
from each stratum defined by population group and menopausal status. This sample size of 
200 was calculated in order to estimate these stratum-specific mean percent MDs within 1% 
at a 95% confidence level, assuming a stratum-specific standard deviation of 7% (for which 
n=180). An additional 20 subjects (∼10% extra) was added to account for potential later 
exclusions (e.g. missing data, image quality poor). When selecting from organized screening 
program databases, we restricted ICMD inclusion to women screened within a recent time 
frame (dates are provided in Table 1).
Mammographic image: types and transfers
So as not to exclude informative populations, there was no restriction on the type of 
mammographic image included, i.e. we included digitized screen-film (analogue) images 
and digital images from both full-field digital mammography (FFDM) and computed 
radiography (CR, an analogue system converted to digital with laser scanner-read plates). 
For digital images, both “raw” (original format) and “processed” (“for presentation”) 
formats were included. The latter is an image manipulated by manufacturer-specific 
algorithms to aid diagnosis. For processed images, we extracted the processing software 
version.
Images were anonymized prior to transfer to IARC via a secure FTP. For the most part, 
anonymization was carried out using NiftyView [22], a cross platform graphical user 
interface provided to collaborators to remove embedded image labels and personal 
information from DICOM tags.
Mammographic Density Measurement
Area-based methods of MD measurement involve partitioning the total breast area into the 
dense area, which represents radio-dense fibro-glandular tissue, and the remaining non-
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dense, which reflects radiolucent adipose tissue. An example of this method is provided in 
Figure 1. PMD is then calculated as 100 × dense area/total breast area. A non-trivial 
challenge in ICMD was to obtain comparable MD measurements across studies, given that 
the images types differed substantially. This task was complicated by the lack of a true 
gold-7 standard measurement method for MD [23], and whilst existing automated methods 
are time-efficient and are predictive of BC risk [24], none could be applied to all of the 
ICMD image types. We thus decided, a priori, to measure MD using the interactive 
thresholding method Cumulus (Dr Martin Yaffe, Sunnybrook Health Sciences Centre, 
Toronto), which can be applied to all DICOM images. Cumulus-measured MD has 
consistently shown strong associations with BC risk [25]. Cumulus version 6 was applied, 
which performs automatic breast edge delimitation, whilst the user delimits other non-breast 
areas manually and sets the greyscale level to dichotomize dense from non-dense greyscale 
levels (Figure 1). We did not choose a categorical classification of MD as it would have less 
statistical power in analysing this quantitative trait. To aid reading, 8-bit digitized images 
were converted to 16-bit prior to reading and raw digital images were inverse log 
transformed.
MD reading protocol
Whilst Cumulus-based MD readings tend to have high repeatability for a given reader, 
readings are reader-specific [26] thus to achieve comparability of MD readings across 
studies we conducted centralized readings by a small team of experienced readers (VM, NB, 
IS) using a protocol designed to ensure no association between study and reader. Studies 
with the same image type (digitized analogue, processed digital or raw digital) were grouped 
(3 to 7 studies per group) and within each group, images were randomly allocated to batches 
of approximately 90 (plus repeats, see following section), which were then divided evenly 
between readers. One image per woman was read and readers were blinded to all personal 
and study information. View, but not laterality, affects measured MD [27], thus if multiple 
views were available, we preferentially read the more widely available left medio-lateral 
oblique (MLO), right-MLO, left cranio-caudal (CC) then right-CC.
Within-reader measurement errors in MD were assessed by re-reading 3 randomly selected 
images within each reading batch, and between-reader differences by re-reading 5 randomly 
selected images from each batch by the other 2 readers. Additionally two batches (at the 
start and towards the end) were read by all 3 readers. A total of 13575 readings were 
completed over an 8 month period across 146 reading batches. The only exception to this is 
the Canadian images which could not be transferred internationally, so they were read by a 
single reader. During the MD assessment process, readers noted features that may impact on 
the MD measurement.
Absolute breast and dense areas in number of pixels were converted to cm2 using the pixel 
size information, which was extracted from DICOM tags or obtained from collaborators 
(Suppl. Table 1). For one study (US-USC), this information was not available for 78 of 444 
images, so these images will be included in PMD but not absolute area-based analyses.
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Risk factor data and its harmonization
Minimal risk factor data required for inclusion were age, height, weight and parity. The first 
three variables were inclusion criteria as age and BMI (calculated as weight/height2 in 
kg/m2) are both strongly inversely related to MD, yet positively associated with 
postmenopausal BC risk, thus the pertinent BC risk factor is percent MD (PMD) or dense 
area for a woman's age and BMI [28]. The timing of height and weight ascertainment, 
ideally, but not always, at the time of mammography, was obtained. In addition to these 
variables, we requested woman-level information on reason for mammography, ethnicity, 
age at menarche, age at first birth, age at last birth, breast feeding durations, use of 
exogenous hormones (i.e. oral contraceptives and hormone therapy), age at menopause, 
reason for menopause, personal cancer history, personal history of breast problems, family 
history of breast cancer, tobacco and alcohol consumption and indicators of socioeconomic 
status. We requested each variable in its original, most basic format and their definitions.
To date, the key variables from study-specific datasets have been merged into a single 
harmonized core dataset. Where definitions of a variable varied between studies (for 
example parity could be defined as the total number of children, number of live births, 
number of full term births,) the definitions were also imported. Continuous variables were 
converted to a common unit of measurement. Some studies collected continuous variables in 
categories (for example, age at first birth). The categorical variable was imported into the 
main dataset as a separate variable and the estimated median of that category pooled with 
the continuous data from other studies. For Figure 4 the categories of age at first birth and 
age at menarche were derived from the continuous variable in the main study dataset, 
therefore for some studies this was the median of the category; study-level definitions for 
age at first birth and parity are shown in Supplemental Table 2.). Whilst the original random 
selection of women from each menopausal group was based on study-specific definitions of 
menopause, those definitions were also individually obtained and will be presented in future 
menopause-focussed investigations.
Data were checked for consistency and implausible values checked. For the core data, adult 
heights less than 1.0 m or over 2.1 m, or with a BMI less than 12 kg/m2 or greater than 80 
kg/m2, were excluded. As the available data on complex lifestyle variables such as 
contraceptive use, hormone therapy, smoking and alcohol use, varied substantially between 
studies, to begin with, these data were pooled into the core dataset into simplified variables 
stating if the participant is a current, past, ever or never user. For future analyses focusing on 
these variables, more complex data will be re-extracted from the original datasets, and their 
definitions and distributions presented at that point.
3. Results and Discussion
Studies included: countries and screening settings
ICMD includes 11755 women from 27 studies across 22 countries. The countries and their 
BC incidence rates are provided in Figure 2. All world regions are included, as are countries 
with 4-fold differences in BC incidence rates, e.g. from ∼25/100,000 in India and Iran, to 
over 90 in the UK and US. The consortium includes less or never-studied countries in terms 
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of MD, notably South Africa, Kenya, Turkey, Iran and India. Most studies were in a 
restricted geographical region of the country, as indicated in Table 1. The table also provides 
further details of study populations. Hereafter, studies will primarily be referred to by their 
country name, with the exception of the multiple studies in the UK and US. Multiple ethnic 
groups were included in the studies from Israel (Jewish and Arab), the UK (White, Black, 
and Asian women), the US (White, Black, Asian and Native Hawaiian), Singapore and 
Malaysia (Malay, Chinese and Indian) and Australia (by country of birth; Australia, Greece 
and Italy).
Amongst the studies included, mammograms were taken in various settings. Over half 
(54%) of ICMD women were screened in organized screening programs (i.e., invitation to 
screening was sent to all women in a defined population) or in the US where screening 
coverage rates are similar to those of organised screening programs. The 13 studies were in 
Israel, The Netherlands, Norway, Spain, Canada, Australia, Japan, the US and all but one of 
the UK studies. For some of these studies risk factors data had been collected as part of 
larger cohorts (US Multiethnic Cohort study, the US Nurses' Health Study (NHS) and NHS 
II, the Melbourne Collaborative Cohort Study) or ICMD women were controls in case-
control studies.
For 20% of ICMD women, screening was opportunistic, e.g. the woman self-presented at a 
screening facility, without an invitation. The ICMD contributions from Egypt, Iran, People's 
Republic of Korea, Malaysia and China Hong Kong came from such settings. For example, 
in the Women's Health Outreach Program in Egypt, women self-present at stationary and 
mobile mammography units throughout the country and risk factor data were routinely 
collected at presentation [29].
Eight percent of women (3 studies) came from general health research studies, in which 
mammograms were conducted for the purposes of the study e.g. mothers in the Chilean 
Cohort Study of Breast Cancer Risk (DERCAM study), the Mexican Teachers' Cohort and a 
study of nurses in Poland. A further three ICMD studies (10% of ICMD women) were 
feasibility studies or trials of mammography. These were a UK screening trial of annual 
mammography ages 39-48 years (UK-Age Trial), the Bahcesehir Breast Cancer Screening 
Project and the Singapore Breast Screening Project.
A challenge in ICMD was to find low-risk settings in which women representative of the 
general population had or were undergoing mammographic screening. The remaining 8% of 
ICMD women, from 3 studies, were from such settings. Mammography was part of ad hoc 
community outreach trials e.g., one-off screening initiatives, where, with the addition of an 
interviewer-administered questionnaire at mammography, relevant data were or would be 
available. The settings were as follows: in India, free mammography was provided to 
women in a rural community during March 2008; in Nairobi, Kenya, the Aga Khan Hospital 
provides low-cost mammography during breast cancer awareness month (October 2013) and 
during visits thereafter until December 2013 women were invited to complete the 
questionnaire; and in South Africa, when the Pink Drive's mobile mammography van was 
providing free community screening in Soweto in 2014, women were invited to take part in 
an interviewer-administered two-page questionnaire.
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Mammographic images
A summary of image types included is provided in Table 2 (and study-specific details in 
Suppl. Table 1). In all, 51.1% of images were digitized screen-film images and the 
remaining images were digital images, of which 9.0% were captured on CR and 91.0% on 
FFDM systems. Machines used in multiple studies include models of the GE Senograph, 
Hologic Lorad Selenia and Siemens Mammomat (Table 2 and Suppl. Table 1). Of the digital 
images, 91.3% were in processed formats and 8.7% were in the original ‘raw’ format.
The vast majority (94.5%) of images were considered of acceptable quality, whilst only 
2.3% were considered suboptimal (due to low resolution, image errors or artefacts) and were 
excluded (Table 2). The main issues with the few remaining images were poor skin visibility 
and truncation of the breast. Where the skin was not visible (1.6% of images), only the dense 
area could be estimated and not total breast area or PMD. Where the skin was ‘barely 
visible’ (0.3% of images) estimates of dense area, total area and PMD were included in the 
main analyses, but will be excluded in sensitivity analyses. This mainly occurred in digitised 
analogue films, perhaps due to a suboptimal optical range of the digitizer. Truncated images 
(0.9%) were often due to the breast being too large for the plate used. For these images, if 
multiple images were taken, they were viewed simultaneously and the image encompassing 
the greater proportion of the breast was read using an estimated enlarged breast area to 
account for the area off the film.
The overall PMD distributions across women in ICMD are shown in Figure 3A, illustrating 
the PMD range from 0 to 80%. Within-reader SDs were much smaller than between-woman 
SDs (Figure 3B), thus each reader had an intra-class correlation over 90%. By design, 
between-study differences will not be due to reader differences, however the reader-specific 
distributions had different degrees of right skewness (skewness parameters by reader are 
0.42, 0.81 and 1.02), thus transformations were needed before linear regression (i.e. normal-
errors) modelling of PMD or of dense-area could be performed. To achieve this, we first 
corrected for batch-drift across each reader's readings by fitting a quadratic association of 
PMD on batch order and predicting batch-corrected PMD as PMD in the absence of batch 
drift as per PMD readings for the batch range where drift was absent. Thereafter, square-root 
transformations were taken of dense area, breast area and PMD, to achieve normally 
distributed outcomes for normal-errors regression models. This transformation has been 
frequently used for area-based MD measures [30]; square-root dense area represents the 
radius of a circle defining the dense area, or the length of the side of a square with dense 
area.
Risk factors: Lifestyle heterogeneity captured
Risk factor information was typically collected by questionnaire at or around 
mammography, with the exception of five studies (table 1), for which explanatory data were 
collected at least 2 years before or several years after mammography. Menopausal status 
was ascertained at the individual level in all but one study. Height and weight were 
measured in 18 of the 27 studies and self-reported by women in the remaining studies. 
Anthropometrics were measured in two-thirds of studies and self-reported in the remaining; 
in most studies they were recorded at the time of mammography (Table 1). The remaining 
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key variables (age at first birth, age at first menstruation and parity) were self-reported in all 
studies.
Median age at mammography was 52 years (90% range 39-66 years) across studies; there 
were over 2000 women in each age interval: 35-44, 45-49, 50-54, 55-59 and 60+ years. 
Most studies span this age range, with the exception of Chile and the UK-Age Trial, which 
by their original study design only included younger populations and studies set in screening 
programs with older recommended screening ages. The wide age range will enable finer 
analyses by age and menopausal status than previously possible.
A flavour of the immense heterogeneity of lifestyles captured in ICMD is shown in Figure 4. 
For each risk factor, population groups were ranked according to the breast cancer risk for 
that factor. Notably, when the top and bottom ranked groups are compared, for every risk 
factor, there were ranges present in one group that do not exist in another. For example, only 
28 (13%) of the 216 women from Hong Kong had a BMI greater than 25 kg/m2, whereas 
only 34 (7%) out of 494 women from Egypt had a BMI below 25 kg/m2 (Figure 4A). The 
stature of women also varied from a mean height of 150.3 cm (SD 5.9) in India to 166.6 cm 
(SD 5.6) in Norway.
The reproductive factors shown in figures 4B-4D are, for the most part, as expected, with 
profiles associated with higher BC risk being more prevalent in higher income countries – 
including earlier menarche, later age at first birth and lower parity – and the reverse was 
seen in transitional countries. However, on closer examination, the risk factor combinations 
in ICMD displayed more complexity, which can be illustrated by comparing women from 
South Africa, Iran and Israel (Arab sub-group). All three groups had amongst the highest 
mean BMIs (Fig. 4A), consistent with the high obesity prevalence in those transitional or 
post-transitional countries [31-33]. These three groups of women also had a relatively young 
age at first birth, with approximately 70% having had their first child by 23 years of age 
(Fig. 4B) - a percentage nearly double that in ICMD groups from Europe and the US. 
However, these 3 groups differed considerably in terms of age at menarche and parity – the 
Israel Arab group of women had a mean age at menarche (12.8 years), i.e., over 2 years 
earlier than their South Africa counterparts (14.9 years). This large difference in means is 
comparable to the size of the secular trends in menarche that occurred over nearly 80 years 
in the UK or US [34,35]. Parity also differed between these groups; whereas the parity of 
South African women is relatively low (median 2-3), 30% of Iranian and 60% of Israeli 
Arab women in ICMD had at least 6 births. These differences are consistent with the timing 
of the fertility transitions, which, although rapid, occurred much later in Iran than in South 
Africa [36,37]. The ICMD pooled data also included many women with very high parity 
(over 700 women with 6 or more births), which will enable an examination of the effect of 
repeated pregnancies on breast composition.
Such heterogeneity is present in several other risk factors, including breastfeeding, alcohol 
intake and smoking habits and will greatly enable the assessment of their influence 
associations with MD.
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Challenges and limitations
A large-scale pooling project such as ICMD, whilst statistically powerful, is not without 
considerable challenges and limitations. First, concerning the representativeness of included 
women, the diversity of screening settings (none of which have complete population 
coverage) will impact on who the ICMD study sample represents - be it the general 
population in the relevant geographical area or a more restricted subset of this population. 
For analyses of the determinants of MD, the generalisability of the MD distribution itself to 
that of a larger study population is not of primary concern, rather it is whether risk factor-
MD associations observed in ICMD are generalizable to the general population. In this 
respect, ICMD study samples that originate from specific occupations (e.g. the NHS and the 
Polish study) or from more affluent or more educated sectors of the population can 
contribute valuably and validly. However, for the investigation of whether population-level 
MD distributions reflect population-level differences in breast cancer incidence rates, 
findings will only be valid if the comparisons of the same underlying populations are made. 
For this component, it should be emphasized that breast cancer incidence rates are not 
estimated from a follow-up of women in ICMD, rather they will be obtained from external 
population-level estimates from cancer registries covering the same or similar catchment 
population. In many settings, screening attendees are more likely to be of higher 
socioeconomic status/educational level and would thus have higher BC incidence rates. 
Such biases are likely to affect studies to greater or lesser degrees depending on the 
screening features, e.g. cost involved, extent of catchment population, how women are 
invited or how screening is advertised. In particular, the study samples from short-term 
once-off screening in Kenya and from opportunistic screening programs may have an over-
representation of more educated women who had to pay for the transport to reach the 
hospital and the fees, albeit reduced, for mammography. The community-level free 
screening in Soweto, South Africa, may have a higher proportion of women with previous 
breast problems, a family history of disease or symptomatic disease.
Second, a further challenge is to create meaningful harmonized risk factor data. Their 
harmonized data may lose precision by collapsing data into simplified variables, but 
analyses will also be conducted on smaller subsets with exposures pooled in finer detail. 
Socioeconomic data do not have the same discriminatory ability or meanings in different 
settings, so within-study categories will be the basis of this exposure.
Finally, the greatest challenge in ICMD is to achieve comparable MD data. Whilst the 
reading protocol should remove reader-effects, image types vary between studies, and a 
whole study's MD readings may be shifted up or down according to the particular system's 
processing algorithm and the reader's interpretation of the threshold cut-point in images 
displayed in raw or in processed formats. Indeed, systematic differences in dense area, 
breast area and in PMD are known to arise from the type of image, e.g. due to processing or 
differential compression [38]. The likely influence on MD needs to be considered as films 
from most studies were of a single image type and could thus act as a strong confounder. 
Further, analogue films originated predominantly from high-risk populations where 
screening occurred in earlier years, as long as 30 years ago, whereas recent films from 
lower-risk populations were more likely to be digital. Two analytical approaches will be 
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taken in an attempt to overcome the potential influence of processing algorithms on MD: (i) 
analyses will first be conducted at the study-level and study-specific effects combined using 
meta-analytic approaches, so that there is no variation in image type within each analysis 
and thus no confounding by image type; (ii) for analyses of the full ICMD dataset within the 
same statistical model, MD values (PMD and dense area) will first be corrected for the 
influence of the image type and processing algorithm. The calibration correction factors will 
be derived from sets of paired digital images that have been stored in both raw and 
processed images (from 2 FFDM and 1 CR system). These results will be presented in a 
separate article.
Summary
ICMD has assembled a rich international resource of individual-level epidemiologic and 
MD information allowing the study of the epidemiology of MD. The risk factor 
heterogeneity captured is extensive and will help elucidate influences on the natural history 
of the breast's fibro-glandular composition. Population shifts in MD distributions are 
relevant for population strategies of disease prevention and require the understanding of the 
determinants of population means, for which ICMD will provide a valuable contribution.
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Highlights
- The International Consortium on Mammographic Density (ICMD) is a pooling 
study of individual-level epidemiologic data and re-read mammographic density 
information.
- The rationale and methods of ICMD are described.
- 11755 women, from 27 studies in 22 countries are included.
- The immense heterogeneity in breast cancer risk factors are highlighted.
McCormack et al. Page 15
Cancer Epidemiol. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. Cumulus-based mammographic density reading
(A) Example from of a FFDM Hologic image as it is first read into Cumulus and (B) after 
Cumulus-version 6 auto-delimits the skin edge and then the user delimits the pectoral 
muscle and selects a threshold to dichotomize the greyscale levels into dense and non-dense 
levels. This 70 μm pixel image was read as: breast area =5155276 pixels = 252.6cm2, dense 
area = 1375976 pixels = 67.4 cm2, thus percent mammographic density (PMD) is 26.7%.
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Figure 2. 
(A) 22 countries participating in ICMD and (B) Ranking of participating countries by their 
age-standardized breast cancer incidence rate in 2012 (from IARC GLOBOCAN 2012 [56])
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Figure 3. 
Density readings across ICMD: (A) Original percent mammographic density (PMD) 
readings, by reader (B) Distribution of within and between-woman standard deviation (SD) 
of PMD across reading batches, for each reader. (C) Distribution of square root PMD by 
reader
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Figure 4. Bar charts of the distribution of (A) BMI, (B) age at menarche, (C) age at first birth 
and (D) parity across the study and ethnic groups included in ICMD
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Table 2
Image characteristics
Mammographic Feature Detail No. studies* No. women (Column %)
Laterality† Left 21 10051 (88.5%)
Right 0 1304 (11.5%)
Mixture within study 6
View MLO 16 6484 (55.2%)
CC 12 5271 (44.8%)
Machine and processing type Digitized Analogue†† 14 6007 (51.1%)
CR Digital - raw 0 0 (0.0%)
CR Digital – processed 2 516 (4.4%)
FFDM – raw 2 500 (4.3%)
FFDM - processed ‡ Kodak Lumisys 85 11 5 4732 (40.3%) 1912 (31.8%)
Digitizer (analogue images only) Array 2905 HD 5 2465 (41.0%)
Lumiscan, Lumisys 1 386 (6.4%)
Astra2400S, UMAX 1 400 (6.7%)
MammoAdvantage 1 400 (6.7%)
Cobrascan/omnimedia 1 444 (7.4%)
DICOM pixel size (μm) < 80 14 5244 (44.6%)
80-109 10 3262 (27.7%)
110-139 0 0 (0.0%)
140-249 6 1877 (16.0%)
250+ 3 935 (8.0%)
Unknown 1 58 (0.5%) - Will be excluded from area-based analyses
Image quality for Cumulus MD reading Acceptable N/A 11106 (94.5%)
Skin barely visible 39 (0.3%)
Other quality issues 36 (0.3%)
Skin not visible 192 (1.6%)
Image truncated 108 (0.9%)
Too poor - EXCLUDE 272 (2.3%)
Abbreviations: CR = computed radiography; FFDM = full-field digital mammography; MD = mammographic density; MLO = mediolateral 
oblique (mammography view); CC = cranio-caudal (mammographic view);
*Some studies contributed a mixture of images types and/or views
†Unknown for 1 study (400 women)
††
Includes 390 images that were printed CR mammograms (Senographe DMR Fuji FCR AC-3CS) and were subsequently digitized (digitizer 
Kodak Lumisys 85)
‡
Type of digital mammography systems and processing algorithm: Fujifilm; Hologic Lorad Selenia; GE Senograph DS / 2000D /Essential; Philips 
Mammodiagnost DR; Agfa DX-M; Siemens Mammomat Inspiration/Novation DR; Medi-Future Brestige
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